• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用阳离子交换层析在单克隆抗体纯化中进行稳健的聚集物去除工艺开发,并实施质量源于设计。

Process development for robust removal of aggregates using cation exchange chromatography in monoclonal antibody purification with implementation of quality by design.

机构信息

Genor Biopharma Co., Ltd., Shanghai, China.

出版信息

Prep Biochem Biotechnol. 2012;42(2):183-202. doi: 10.1080/10826068.2012.654572.

DOI:10.1080/10826068.2012.654572
PMID:22394066
Abstract

Aggregate removal is one of the most important aspects in monoclonal antibody (mAb) purification. Cation-exchange chromatography (CEX), a widely used polishing step in mAb purification, is able to clear both process-related impurities and product-related impurities. In this study, with the implementation of quality by design (QbD), a process development approach for robust removal of aggregates using CEX is described. First, resin screening studies were performed and a suitable CEX resin was chosen because of its relatively better selectivity and higher dynamic binding capacity. Second, a pH-conductivity hybrid gradient elution method for the CEX was established, and the risk assessment for the process was carried out. Third, a process characterization study was used to evaluate the impact of the potentially important process parameters on the process performance with respect to aggregate removal. Accordingly, a process design space was established. Aggregate level in load is the critical parameter. Its operating range is set at 0-3% and the acceptable range is set at 0-5%. Equilibration buffer is the key parameter. Its operating range is set at 40 ± 5 mM acetate, pH 5.0 ± 0.1, and acceptable range is set at 40 ± 10 mM acetate, pH 5.0 ± 0.2. Elution buffer, load mass, and gradient elution volume are non-key parameters; their operating ranges and acceptable ranges are equally set at 250 ± 10 mM acetate, pH 6.0 ± 0.2, 45 ± 10 g/L resin, and 10 ± 20% CV respectively. Finally, the process was scaled up 80 times and the impurities removal profiles were revealed. Three scaled-up runs showed that the size-exclusion chromatography (SEC) purity of the CEX pool was 99.8% or above and the step yield was above 92%, thereby proving that the process is both consistent and robust.

摘要

聚集物去除是单克隆抗体(mAb)纯化中最重要的方面之一。阳离子交换色谱(CEX)是 mAb 纯化中广泛使用的一种抛光步骤,能够清除工艺相关杂质和产品相关杂质。在这项研究中,采用质量源于设计(QbD),描述了使用 CEX 稳健去除聚集物的工艺开发方法。首先进行了树脂筛选研究,并选择了一种合适的 CEX 树脂,因为它具有相对更好的选择性和更高的动态结合能力。其次,建立了 CEX 的 pH-电导率混合梯度洗脱方法,并对工艺进行了风险评估。第三,采用工艺特性研究评估了潜在重要工艺参数对聚集物去除工艺性能的影响。相应地,建立了工艺设计空间。负载中的聚集物水平是关键参数。其操作范围设定为 0-3%,可接受范围设定为 0-5%。平衡缓冲液是关键参数。其操作范围设定为 40 ± 5 mM 醋酸盐,pH 5.0 ± 0.1,可接受范围设定为 40 ± 10 mM 醋酸盐,pH 5.0 ± 0.2。洗脱缓冲液、负载量和梯度洗脱体积是非关键参数;它们的操作范围和可接受范围同样设定为 250 ± 10 mM 醋酸盐,pH 6.0 ± 0.2,45 ± 10 g/L 树脂和 10 ± 20%CV。最后,将工艺放大 80 倍,揭示了杂质去除情况。三次放大运行表明,CEX 池的尺寸排阻色谱(SEC)纯度为 99.8%或更高,收率高于 92%,从而证明该工艺既一致又稳健。

相似文献

1
Process development for robust removal of aggregates using cation exchange chromatography in monoclonal antibody purification with implementation of quality by design.采用阳离子交换层析在单克隆抗体纯化中进行稳健的聚集物去除工艺开发,并实施质量源于设计。
Prep Biochem Biotechnol. 2012;42(2):183-202. doi: 10.1080/10826068.2012.654572.
2
pH-conductivity hybrid gradient cation-exchange chromatography for process-scale monoclonal antibody purification.用于工艺规模单克隆抗体纯化的pH-电导率混合梯度阳离子交换色谱法
J Chromatogr A. 2007 Dec 14;1175(1):69-80. doi: 10.1016/j.chroma.2007.10.028. Epub 2007 Oct 17.
3
Exploration of overloaded cation exchange chromatography for monoclonal antibody purification.过载阳离子交换层析法在单克隆抗体纯化中的应用探索。
J Chromatogr A. 2011 Sep 28;1218(39):6943-52. doi: 10.1016/j.chroma.2011.08.008. Epub 2011 Aug 12.
4
Cation exchange chromatography provides effective retrovirus clearance for antibody purification processes.阳离子交换色谱法为抗体纯化过程提供了有效的逆转录病毒清除效果。
Biotechnol Bioeng. 2012 Jan;109(1):157-65. doi: 10.1002/bit.23300. Epub 2011 Aug 23.
5
Evaluation of high-capacity cation exchange chromatography for direct capture of monoclonal antibodies from high-titer cell culture processes.评估高容量阳离子交换色谱法从高滴度细胞培养工艺中直接捕获单克隆抗体的能力。
Biotechnol Bioeng. 2014 Jul;111(7):1354-64. doi: 10.1002/bit.25192. Epub 2014 Feb 21.
6
Resolution of heterogeneous charged antibody aggregates via multimodal chromatography: a comparison to conventional approaches.通过多模式色谱法解析异质带电抗体聚集体:与传统方法的比较
Biotechnol Prog. 2014 May-Jun;30(3):636-45. doi: 10.1002/btpr.1908. Epub 2014 Apr 19.
7
The impact of protein exclusion on the purity performance of ion exchange resins.
Biotechnol Bioeng. 2009 Feb 15;102(3):971-6. doi: 10.1002/bit.22101.
8
Cation exchange frontal chromatography for the removal of monoclonal antibody aggregates.阳离子交换前沿色谱法去除单克隆抗体聚集体。
J Chromatogr A. 2019 Aug 16;1599:152-160. doi: 10.1016/j.chroma.2019.04.020. Epub 2019 Apr 9.
9
Modeling and robust pooling design of a preparative cation-exchange chromatography step for purification of monoclonal antibody monomer from aggregates.制备型阳离子交换层析一步法分离单克隆抗体单体和聚集体的模型建立和稳健集设计。
J Chromatogr A. 2014 Sep 12;1359:170-81. doi: 10.1016/j.chroma.2014.07.041. Epub 2014 Jul 21.
10
Development and application of an automated, low-volume chromatography system for resin and condition screening.一种用于树脂和条件筛选的自动化小体积色谱系统的开发与应用。
Biotechnol J. 2008 Oct;3(9-10):1212-23. doi: 10.1002/biot.200700265.

引用本文的文献

1
Antibody Aggregate Removal by Multimodal Chromatography.通过多模式色谱法去除抗体聚集体
Molecules. 2025 May 29;30(11):2363. doi: 10.3390/molecules30112363.
2
A Novel 3D-Printed and Miniaturized Periodic Counter Current Chromatography System for Continuous Purification of Monoclonal Antibodies.一种用于连续纯化单克隆抗体的新型3D打印小型化周期逆流色谱系统。
Micromachines (Basel). 2024 Mar 13;15(3):382. doi: 10.3390/mi15030382.
3
Challenges and solutions for the downstream purification of therapeutic proteins.治疗性蛋白质下游纯化的挑战与解决方案
Antib Ther. 2023 Nov 19;7(1):1-12. doi: 10.1093/abt/tbad028. eCollection 2024 Jan.
4
Risk-Based Control Strategies of Recombinant Monoclonal Antibody Charge Variants.重组单克隆抗体电荷变体的基于风险的控制策略
Antibodies (Basel). 2022 Nov 20;11(4):73. doi: 10.3390/antib11040073.
5
Downstream Processing Technologies/Capturing and Final Purification : Opportunities for Innovation, Change, and Improvement. A Review of Downstream Processing Developments in Protein Purification.下游加工技术/捕获与最终纯化:创新、变革与改进的机遇。蛋白质纯化下游加工发展综述。
Adv Biochem Eng Biotechnol. 2018;165:115-178. doi: 10.1007/10_2017_12.
6
Design space development for the extraction process of Danhong injection using a Monte Carlo simulation method.采用蒙特卡罗模拟方法进行丹红注射液提取工艺的设计空间开发。
PLoS One. 2015 May 28;10(5):e0128236. doi: 10.1371/journal.pone.0128236. eCollection 2015.
7
Preparative purification of recombinant proteins: current status and future trends.重组蛋白的制备性纯化:现状与未来趋势
Biomed Res Int. 2013;2013:312709. doi: 10.1155/2013/312709. Epub 2013 Dec 17.